Merck & Co Inc MRK
News
Merck Raises Quarterly Dividend by 3.5%
Merck Gains Support for Broader Use of Preventive RSV Treatment
The science of vaccines is rapidly advancing - despite the anti-vax movement
Merck Says Investigational MASH Drug Shows Promise in Midstage Trial
Moderna Swings to 3Q Profit, Lifts Outlook as Covid-19 Vaccine Demand Stabilizes — Update
The big winners of the tech wreck are biopharma stocks
Lilly raised sales guidance for third time this year as Zepbound sales soar. Its stock closed at a record high.
Merck 3Q Revenue Up on Keytruda, Winrevair Growth — Update
Merck 3Q Revenue Up on Keytruda, Winrevair Growth
The excitement around Moderna's cancer vaccine is cooling. Here's why.
Moderna's cancer vaccine is 'likely' to get approved. Skeptics question if it will be the best option.
Moderna's cancer vaccine hits its targets, but a data leak rattled investors and the stock tumbled
Moderna has a plan to revolutionize how certain cancers are treated. We're about to find out its potential in melanoma.
7 healthcare stocks that stand out as investors pay up for the sector
7 healthcare stocks that stand out as -2-
Big pharma stocks close near all-time highs as tech selloff pushes investors toward safer bets
Formycon Shares Jump After FDA Accepts Application for Keytruda Biosimilar
Halozyme Wins Injunction Against Merck in Keytruda Patent Case — Update
Halozyme Granted Another Injunction Against Merck in Keytruda Patent Case

